{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T10:01:01Z","timestamp":1768989661770,"version":"3.49.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,5]],"date-time":"2023-10-05T00:00:00Z","timestamp":1696464000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejog.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/j.ejogrb.2023.10.004","type":"journal-article","created":{"date-parts":[[2023,10,6]],"date-time":"2023-10-06T11:30:00Z","timestamp":1696591800000},"page":"128-130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Asymptomatic CMV infection at birth following maternal primary infection despite valacyclovir treatment and a subsequent negative amniocentesis. Case report"],"prefix":"10.1016","volume":"291","author":[{"given":"Maria Stefania","family":"Toti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorenzo","family":"Zammarchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucia","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irene","family":"Campolmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Modi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Borchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandro","family":"Bartoloni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michele","family":"Trotta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luisa","family":"Galli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roberto","family":"Bernardini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejogrb.2023.10.004_b0005","first-page":"355","article-title":"New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection","volume":"17","author":"Dollard","year":"2007","journal-title":"Revista M\u00e9dicaVirol"},{"issue":"20","key":"10.1016\/j.ejogrb.2023.10.004_b0010","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1056\/NEJMra050700","article-title":"Newborn hearing screening\u2014a silent revolution","volume":"354","author":"Morton","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.10.004_b0015","first-page":"253","article-title":"Review and metaanalysis of the epidemiology of congenital cytomegalovirus (CMV) infection","volume":"17","author":"Kenneson","year":"2007","journal-title":"Revista M\u00e9dicaVirol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.10.004_b0020","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1080\/14767058.2017.1387890","article-title":"Prevention and treatment of fetal cytomegalovirus infection with cytomegalovirus hyperimmune globulin a multicenter study in Madrid","volume":"32","author":"Bl\u00e1zquez-Gamero","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.ejogrb.2023.10.004_b0025","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1002\/uog.19164","article-title":"Prevention of maternal-fetal transmission of cytomegalovirus after primary maternal infection in the first trimester by biweekly hyperimmunoglobulin administration","volume":"53","author":"Kagan","year":"2019","journal-title":"UltrasoundObstet Gynecol"},{"key":"10.1016\/j.ejogrb.2023.10.004_b0030","unstructured":"Hughes BL. A randomized trial to prevent congenital CMV. ID Week; 2020, October 21- 25, 2019, Philadelphia, PA."},{"issue":"14","key":"10.1016\/j.ejogrb.2023.10.004_b0035","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1310214","article-title":"A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus","volume":"370","author":"Revello","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.10.004_b0040","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1002\/uog.23596","article-title":"Outcome of pregnancies with recent primary cytomegalovirus infection in first trimester treated with hyperimmunoglobulin: observational study","volume":"57","author":"Kagan","year":"2021","journal-title":"UltrasoundObstet Gynecol"},{"issue":"10253","key":"10.1016\/j.ejogrb.2023.10.004_b0045","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/S0140-6736(20)31868-7","article-title":"Valaciclovir to prevent vertical transmission of cytomegalovirus after maternal primary infection during pregnancy: a randomised, double-blind, placebo-controlled trial","volume":"396","author":"Shahar-Nissan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.ejogrb.2023.10.004_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcv.2020.104351","article-title":"Valacyclovir in primary maternal CMV infection for prevention of vertical transmission: a case-series","volume":"127","author":"De Santis","year":"2020","journal-title":"J Clin Virol"},{"key":"10.1016\/j.ejogrb.2023.10.004_b0055","doi-asserted-by":"crossref","unstructured":"Faure-Bardon V, Fourgeaud J, Stirnemann J, Leruez-Ville M, Ville Y. Secondary prevention of congenital CMV infection with valaciclovir following maternal primary infection in early pregnancy. Ultrasound in Obstetrics & Gynecology. Published online May 16, 2021. doi:10.1002\/uog.23685.","DOI":"10.1002\/uog.23685"},{"key":"10.1016\/j.ejogrb.2023.10.004_b0060","article-title":"New data on efficacy of valaciclovir in secondary prevention of maternal-fetal transmission of CMV","author":"Egloff","year":"2022","journal-title":"UltrasoundObstet Gynecol"},{"issue":"4","key":"10.1016\/j.ejogrb.2023.10.004_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2016.04.003","article-title":"In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study","volume":"215","author":"Leruez-Ville","year":"2016","journal-title":"Am J Obstet Gynecol"},{"issue":"9","key":"10.1016\/j.ejogrb.2023.10.004_b0070","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/j.cmi.2020.04.006","article-title":"Management of cytomegalovirus infection in pregnancy: is it time for valacyclovir?","volume":"26","author":"Zammarchi","year":"2020","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.10.004_b0075","first-page":"299","article-title":"Valacyclovir for prevention and treatment of fetal CMV infection: inclusion in the Law 648\/96 list and launch of the Italian multicentre observational prospective study \u201cMEGALITALI\u201d","volume":"29","author":"Zammarchi","year":"2021","journal-title":"Infez Med"},{"key":"10.1016\/j.ejogrb.2023.10.004_b0080","unstructured":"Inserimento del medicinale \u00abValaciclovir\u00bb (originatore o biosimilare) nell\u2019elenco dei medicinali erogabili a totale carico del Servizio sanitario nazionale, per la prevenzione dell\u2019infezione fetale e il trattamento della malattia fetale da citomegalovirus. (Determina n. 142618\/2020). (20A07138) Gazzetta Ufficiale - Serie Generale; n.322 del 30-12-2020.www.gazzettaufficiale.it."},{"issue":"4","key":"10.1016\/j.ejogrb.2023.10.004_b0085","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.jcv.2010.12.012","article-title":"Role of prenatal diagnosis and counseling in the management of 735 pregnancies complicated by primary human cytomegalovirus infection: a 20year experience","volume":"50","author":"Revello","year":"2011","journal-title":"J Clin Virol"},{"issue":"2","key":"10.1016\/j.ejogrb.2023.10.004_b0090","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/uog.26128","article-title":"Neonatal and long-term outcomes of infants with congenital cytomegalovirus infection and negative amniocentesis: systematic review and meta-analysis","volume":"61","author":"Chatzakis","year":"2023","journal-title":"UltrasoundObstet Gynecol"},{"issue":"10","key":"10.1016\/j.ejogrb.2023.10.004_b0095","article-title":"Treatment with valacyclovir during pregnancy for prevention of congenital cytomegalovirus infection: a real-life multicenter Italian observational study","volume":"5","author":"Zammarchi","year":"2023","journal-title":"Am J Obstet Gynecol MFM."},{"issue":"4","key":"10.1016\/j.ejogrb.2023.10.004_b0100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmi.2020.09.015","article-title":"Valacyclovir for cytomegalovirus infection in pregnancy: additional evidences, additional questions","volume":"27","author":"Zammarchi","year":"2021","journal-title":"Clin Microbiol Infect"},{"issue":"125","key":"10.1016\/j.ejogrb.2023.10.004_b0105","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.ijid.2022.09.038","article-title":"Recurrent congenital cytomegalovirus infection in a sequential pregnancy with severe sequelae, and a possible association with prophylactic valacyclovir treatment: a case report","volume":"10","author":"Brosh-Nissimov","year":"2022","journal-title":"Int J Infect Dis"},{"issue":"1","key":"10.1016\/j.ejogrb.2023.10.004_b0110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1093\/cid\/ciw237","article-title":"Clinical Implications for Children Born With Congenital Cytomegalovirus Infection Following a Negative Amniocentesis","volume":"63","author":"Bilavsky","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.ejogrb.2023.10.004_b0115","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.jogc.2021.05.015","article-title":"420: Cytomegalovirus Infection in Pregnancy","volume":"43","author":"Boucoiran","year":"2021","journal-title":"J Obstet Gynaecol Can"}],"container-title":["European Journal of Obstetrics & Gynecology and Reproductive Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523007558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301211523007558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T06:02:32Z","timestamp":1759557752000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301211523007558"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12]]},"references-count":23,"alternative-id":["S0301211523007558"],"URL":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.10.004","relation":{},"ISSN":["0301-2115"],"issn-type":[{"value":"0301-2115","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asymptomatic CMV infection at birth following maternal primary infection despite valacyclovir treatment and a subsequent negative amniocentesis. Case report","name":"articletitle","label":"Article Title"},{"value":"European Journal of Obstetrics & Gynecology and Reproductive Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejogrb.2023.10.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}